IPD 4.76% 8.8¢ impedimed limited

Collaborative Care: The Key to Effective Lymphedema Management...

  1. 148 Posts.
    lightbulb Created with Sketch. 71
    Collaborative Care: The Key to Effective Lymphedema Management (linkedin.com)

    Great to see a big lymphedema training/course provider in the US mentioning Bioimpedance in their Jan 2024 update. Australasian lymphology Assocation (ALA) has been educating people about BIS for years in Australia and is a big reason that BIS is more known about and adopted in Australia. Impedimed supported ALA and is listed as a silver partner on their website. Progress with US training providers could prove very significant. I wonder if this has come about due to NCCN guideline inclusion.

    See a snippet below from the linkedin article

    "The Role of Technology and Innovation

    Advancements in technology, such as bioimpedance spectroscopy for early detection and telemedicine for remote monitoring, are becoming increasingly important in lymphedema management. These innovations allow for earlier intervention and more efficient care coordination among medical teams."

 
watchlist Created with Sketch. Add IPD (ASX) to my watchlist
(20min delay)
Last
8.8¢
Change
0.004(4.76%)
Mkt cap ! $178.0M
Open High Low Value Volume
8.5¢ 8.8¢ 8.5¢ $58.34K 679.9K

Buyers (Bids)

No. Vol. Price($)
2 11603 8.7¢
 

Sellers (Offers)

Price($) Vol. No.
8.8¢ 85000 1
View Market Depth
Last trade - 10.42am 16/05/2024 (20 minute delay) ?
Last
9.0¢
  Change
0.004 ( 7.91 %)
Open High Low Volume
8.5¢ 9.0¢ 8.5¢ 89300
Last updated 11.09am 16/05/2024 ?
IPD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.